about
sameAs
FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cellsIdentification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size controlRole of FIP200 in cardiac and liver development and its regulation of TNFalpha and TSC-mTOR signaling pathwaysAutophagy in malignant transformation and cancer progressionThe multifaceted roles of autophagy in tumors-implications for breast cancer.Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosisGrowth suppression and radiosensitivity increase by HMGB1 in breast cancerST18 is a breast cancer tumor suppressor gene at human chromosome 8q11.2.Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors.RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.p62/SQSTM1 synergizes with autophagy for tumor growth in vivo.RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patientsDownregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity.Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancerFrom latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.The COP1 E3-ligase interacts with FIP200, a key regulator of mammalian autophagy.Lifetime risks of common cancers among retinoblastoma survivors.Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesisThe retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.Mitophagy and cancer.RB1CC1 protein suppresses type II collagen synthesis in chondrocytes and causes dwarfismSomatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomasmiR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death.The ETS factor TEL2 is a hematopoietic oncoprotein.FIP200, a key signaling node to coordinately regulate various cellular processes.Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer.The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomasInactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models.The molecular genetics of breast cancer and targeted therapyAutophagy and tumorigenesis.Autophagy: for better or for worse.RB1CC1 protein positively regulates transforming growth factor-beta signaling through the modulation of Arkadia E3 ubiquitin ligase activity.Suppression of autophagy by FIP200 deletion impairs DNA damage repair and increases cell death upon treatments with anticancer agents.Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.Conserved RNA secondary structures promote alternative splicing.Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activityNeoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value.FIP200 inhibits β-catenin-mediated transcription by promoting APC-independent β-catenin ubiquitination.Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.Defining the genetic components of callus formation: A GWAS approach
P2860
Q24648105-F16919F0-8F1B-4AA1-BA7A-AB10FF334D14Q24679076-91283CC3-077A-4F4E-96B6-95978B3D75F3Q24682845-A38178C6-0415-48A0-B0F5-63CA7175CD4AQ27000191-4962D4AE-45D5-4456-8B61-EF18939AABDBQ27692102-C3D004A5-364C-4007-9A0B-DBB71693DF3DQ28200959-65818655-2A5F-45D2-B4D2-71706990ECAEQ28258375-3AA92CC0-434E-4D75-8728-2E5561A29B44Q30032679-D720DD21-854C-4959-B045-A4E05F291745Q33514850-B29862C4-7C38-4D99-8CB7-4C37C8F4E1D5Q33627736-416B3BAE-007F-4F77-A712-7D87A7169453Q33738032-1AD220EF-D634-4F2E-88FB-D75342CEC1C2Q33784718-8B2FA432-1C41-46ED-8D99-72BB1CBF9445Q33908259-6C266C4D-AE0C-4B46-B8AC-125666B2BF7BQ33952990-85BEF20C-A867-4F17-8499-9DD03DBCAD2CQ34206149-37AE5EC3-90C8-4759-9437-7D5C4D12A221Q34536855-D513F36B-D3D1-4A4D-8017-80F15D64594EQ34546040-BE4599CF-5206-420D-9755-E6C7A268898CQ35128818-3BB0ECCF-9A07-45B8-A581-55D1768517D2Q35191588-6A57D813-42D8-422B-A5C1-2D2234CDB07CQ35215652-4FE0CFEC-0698-4D16-90B8-05C765D9A6B3Q35626134-0B27BD14-9180-46D7-B80E-CD9088A26CCDQ35749438-D438F31E-6596-4671-985D-D8316AB4E689Q35837541-5F18D9CF-D136-421F-8CFA-C8976344F0F5Q35850023-C4F00E5C-4A0B-45DE-8E73-8DBA64658D45Q36515638-C2421E43-41F1-44E0-AF58-A19DDCBFCDD6Q36840167-A0AA0230-4B34-4608-812D-A05F49A84245Q37038629-E36E5508-F506-4860-A81E-642DE0761FE7Q37104726-8787B55A-A5D7-4A6B-9E91-A3EEA2FF736BQ37290512-EC73E181-CF0F-4F42-98E6-B4AD7BE38538Q37768714-2041B807-846F-4626-B566-C7CA1E04CD68Q37930982-E9D8C737-A7FB-4470-85A4-1AF944EC9422Q38420659-39D8F8E0-E38D-4E93-B932-B295113CB48CQ38498596-7066F57C-DD0F-41C3-883C-D2F4D6A91C10Q38703282-A07663D3-139D-4CE9-A59C-E3F1A097001BQ41210059-7F36270D-9EBA-41D1-B42D-BB27E4CA24F9Q41939510-AE08E8FD-E4FB-4531-A6FD-1DF7A87A13FAQ49622309-0F90C380-CFD0-461A-A660-034CB6F47857Q54333338-A372F9F8-37A1-43F0-8181-F9EA6249AC1EQ54976490-74B4614E-D5BC-4BFD-9DD4-A051317637ADQ58771620-53DB2A71-18CE-41C0-914A-35EDBAEBDD37
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Truncating mutations of RB1CC1 in human breast cancer
@ast
Truncating mutations of RB1CC1 in human breast cancer
@en
Truncating mutations of RB1CC1 in human breast cancer
@nl
type
label
Truncating mutations of RB1CC1 in human breast cancer
@ast
Truncating mutations of RB1CC1 in human breast cancer
@en
Truncating mutations of RB1CC1 in human breast cancer
@nl
prefLabel
Truncating mutations of RB1CC1 in human breast cancer
@ast
Truncating mutations of RB1CC1 in human breast cancer
@en
Truncating mutations of RB1CC1 in human breast cancer
@nl
P2093
P2860
P356
P1433
P1476
Truncating mutations of RB1CC1 in human breast cancer
@en
P2093
Hidetoshi Okabe
Keiichi Kontani
Koji Teramoto
Shiro Ikegawa
P2860
P2888
P356
10.1038/NG911
P407
P577
2002-07-01T00:00:00Z